Program
Scientific Program
- May 14 (Thu)
- 09:00-11:30
- Year in Review
- Room 1 (3F)
- KOR (ENG Translation)
- Chairs
- Geun Tae Kim (Kosin Univ., Korea)
- Bo Young Yoon (Inje Univ., Korea)
09:00-09:30
Emerging Treatments in Rheumatoid Arthritis
09:30-10:00
Psoriatic Arthritis
10:00-10:30
Recent Advances in Lupus Nephritis: A Year in Review
10:30-11:00
Sjögren's Disease
11:00-11:30
ANCA-Associated Vasculitis
- May 14 (Thu)
- 12:00-13:00
- Luncheon Symposium 1 [Celltrion]
- Efficacy of Infliximab SC in Treatment of axSpA
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
12:00-13:00
From Clinical Trials to Real-World Evidence: The Totality of Evidence for Subcutaneous Infliximab
- May 14 (Thu)
- 13:00-14:30
- Presidential Plenary Session
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
13:00-13:40
A Life So Good, Unique
13:40-14:20
Charting a Path to Research Excellence in Rheumatology
- May 14 (Thu)
- 15:30-17:00
- International Joint Symposium (KCR and APLAR member)
- Room 1 (3F)
- ENG
- Chairs
- Kichul Shin (Seoul Nat'l Univ., Korea)
- Lai-Shan Tam (The Chinese Univ. of Hong Kong, Hong Kong)
15:30-15:50
Prevention of Bone Damage in Psoriatic Arthritis
15:50-16:10
Driving Quality Care in RA in the APLAR Region: Leveraging Registry Data from Patients and Clinicians
16:10-16:30
State-of-the-Art Systemic Lupus Erythematosus
16:30-16:50
Social Justice and Rheumatology
- May 14 (Thu)
- 17:00-18:00
- Evening Symposium 1 [Novartis]
- Transforming Lives: Breakthrough Innovations in Autoimmune Disease
- Room 1 (3F)
- ENG
- Chair
- Kyung-Su Park (The Catholic Univ. of Korea, Korea)
17:00-18:00
Unlocking Sjögren’s Disease: Evolving landscape in Sjögren’s Disease Management
- May 14 (Thu)
- 12:00-13:00
- Luncheon Symposium 2 [Samsung Bioepis]
- Spondyloarthritis
- Room 2 (3F)
- ENG
- Chair
- Bin Yoo (Univ. of Ulsan, Korea)
12:00-13:00
The Evolving Landscape of axSpA Treatment: Real-World Insights from the European Experience
- May 14 (Thu)
- 13:00-14:30
- Free Paper Session 1_Systemic Lupus Erythematosus (SLE)
- Room 2 (3F)
- ENG
- Chairs
- Hye-Soon Lee (Hanyang Univ., Korea)
- Chang-Hee Suh (Ajou Univ., Korea)
13:00-13:10
(KO-001) Mendelian Randomization and Transcriptomics Reveal That RNASET2 Dysfunction in Immune Cells Increases the Risk of Systemic Lupus Erythematosus
13:10-13:20
(KO-002) Accumulation of Terminally Exhausted T-cells in the Kidneys of MRL/lpr Mice Is Correlates with Serum Levels of Interferon-γ-Inducible Protein 10
13:20-13:30
(KO-003) 3H-1,2-Dithiole-3-Thione Modulates Pathogenic B Cell Responses and Ameliorates Lupus Nephritis in C57BL/6 Lpr Mice
13:30-13:40
(KO-004) Therapeutic Potential of Immunoregulatory Gut Microbiota and Fecal Metabolites in Preclinical Models of Lupus
13:40-13:50
(KO-005) Dysregulation of Sphingosine-1-phosphate Signaling in Systemic Lupus Erythematosus and Its Therapeutic Implications
13:50-14:00
(KO-006) A Patient-derived Humanized Mouse Avatar Platform for Monitoring Disease Activity and Personalized Drug Screening in Systemic Lupus Erythematosus
14:00-14:10
(KO-007) A Study on a Computational Fluid Dynamics-based Model of Systemic Lupus Erythematosus Vasculitis
14:10-14:20
(KO-008) Real-world Outcomes of Belimumab or Calcineurin Inhibitor Add-on Therapy to Mycophenolate in Lupus Nephritis
14:20-14:30
(KO-009) Serum IL-32γ as a Biomarker for Remission Assessment in Systemic Lupus Erythematosus
- May 14 (Thu)
- 15:30-17:00
- Free Paper Session 2_SLE & Antiphospholipid Syndrome and Sjögren's Syndrome
- Room 2 (3F)
- ENG
- Chairs
- Young Ho Lee (Korea Univ., Korea)
- Seung-Ki Kwok (The Catholic Univ. of Korea, Korea)
15:30-15:40
(KO-010) Histological Evolution and Clinical Impact of Repeat Renal Biopsy in Lupus Nephritis
15:40-15:50
(KO-011) Association between Antiphospholipid Antibodies and Subclinical Carotid Atherosclerosis in Systemic Lupus Erythematosus: A Cohort-based Study
15:50-16:00
(KO-012) Differences between the 2006 Revised Sapporo Classification Criteria and 2023 ACR/EULAR Classification Criteria for Antiphospholipid Syndrome: A Multicenter Validation Study
16:00-16:10
(KO-013) S100A4 and S100A7 as Markers of Immune Activation in Sjögren’s Syndrome
16:10-16:20
(KO-014) Dissecting the Immune Genetic Architecture of Sjögren’s Syndrome Using a Single-cell Causal Framework
16:20-16:30
(KO-015) Clinical Characteristics of Sjögren’s Disease Patients Presenting with Glandular Swelling at Diagnosis: A Single-center Cohort Study
16:30-16:40
(KO-016) Time-dependent Progression of Salivary Gland Ultrasound Abnormalities in Sjögren’s Disease: A Longitudinal Single-center Prospective Cohort Study
16:40-16:50
(KO-017) Patient-reported Experiences and Disease Burden of Sjögren’s Disease in Korea: A Nationwide Multicenter Survey Adapted from the Sjögren’s Foundation Questionnaire (PRESS Study)
16:50-17:00
(KO-018) Nine-year Longitudinal Changes in Salivary Gland Ultrasonography in Primary Sjögren’s Disease
- May 14 (Thu)
- 17:00-18:00
- Evening Symposium 2 [Johnson&Johnson]
- SIMPONI SC Efficacy in AS
- Room 2 (3F)
- ENG
- Chair
- Seong-Ho Kim (Inje Univ., Korea)
17:00-18:00
Improving Treatment Persistence with Golimumab: Low Immunogenicity and Management of Extra-musculoskeletal Manifestations
- May 14 (Thu)
- 12:00-13:00
- Luncheon Symposium 3 [GSK]
- Shingles Prevention as a Priority in Rheumatology
- Room 3 (5F)
- ENG
- Chair
- Eun Bong Lee (Seoul Nat'l Univ., Korea)
12:00-13:00
Timings and Targets in Vaccine-Preventable Diseases: Shingles Prevention in Rheumatology
- May 14 (Thu)
- 13:00-14:30
- Free Paper Session 3_Systemic Sclerosis and Vasculitis
- Room 3 (5F)
- ENG
- Chairs
- Chan-Bum Choi (Hanyang Univ., Korea)
- Hyun-Sook Kim (Soonchunhyang Univ., )
13:00-13:10
(KO-019) Obacunone Modulates GPX4-associated Ferroptosis and Attenuates Skin Fibrosis in Bleomycin-induced Systemic Sclerosis Model
13:10-13:20
(KO-020) Dual Therapeutic Potential of FTY720 in Systemic Sclerosis: Modulation of Pathogenic Th2/Th17 Responses and Enrichment of Beneficial Gut Microbiota
13:20-13:30
(KO-021) Targeted Immunotherapy for Systemic Sclerosis: CNP-D/R/V Nano-vaccine Reverses Fibrosis by Modulating the Th17/Treg Balance in an Antigen-specific Manner
13:30-13:40
(KO-022) GSDMD mRNA and Serum IL-1βas Potential Biomarkers for Early-stage Systemic Sclerosis: Correlation with Scl-70 Subtype and Organ Damage
13:40-13:50
(KO-023) Deep Learning Framework for the Diagnosis of Systemic Sclerosis Using Serum-derived Microbial Signatures
13:50-14:00
(KO-024) Clinical Characteristics and Factors Associated with Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis-associated Interstitial Lung Disease
14:00-14:10
(KO-025) Rapamycin Inhibits the Polarisation of CD4+ T Cells towards TH1 Cells in Patients with Active Granulomatosis with Polyan-giitis and Microscopic Polyangiitis
14:10-14:20
(KO-026) Large-vessel FDG Uptake on PET/CT in Patients with ANCA-associated Vasculitis: Implications for Classification and Interpretation
14:20-14:30
(KO-027) Peripheral Arterial Assessment as a Complementary Tool in the Evaluation of Cutaneous Arteritis
- May 14 (Thu)
- 15:30-17:00
- Free Paper Session 4_Myositis and Metabolic Bone Diseases
- Room 3 (5F)
- ENG
- Chairs
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- Jinhyun Kim (Chungnam Nat'l Univ., Korea)
15:30-15:40
(KO-028) Bioinformatics-inferred Autoantibody-linked Tissue-specific Plasma Proteomic Endotypes in New-onset Juvenile Dermatomyositis Predict Persistent Disease Activity and Endothelial Vasculopathy Risk Using Longitudinal Pediatric Cohort
15:40-15:50
(KO-029) Untargeted Metabolomic Profiling Identified Increased Kynurenine-related Pathway in Idiopathic Inflammatory Myopathy
15:50-16:00
(KO-030) PEX5 Acts as a Negative Regulator of RANKL-induced Osteoclastogenesis in Vitro and Inflammatory Calvarial Bone Destruction in Vivo
16:00-16:10
(KO-031) The Essential Role of Osteoclast-derived DPP4 in Bone Regeneration and Fracture Healing
16:10-16:20
(KO-032) Calcium Carbonate or Sodium Bicarbonate Combination Prevent Esomeprazole-induced Osteoporosis in Rat
16:20-16:30
(KO-033) The Association between Abdominal Muscle Mass and Osteoporosis in Postmenopausal Women
16:30-16:40
(KO-034) Effect of Janus Kinase Inhibitors on Bone Mineral Density in Rheumatoid Arthritis Patients with Osteoporosis: A Comparative Study with Biologics Therapy
16:40-16:50
(KO-035) Long Term Outcomes of Kudo Type Total Elbow Arthroplasty in Rheumatoid Arthritis
- May 14 (Thu)
- 17:00-17:40
- Building the KCR Rheumatoid Arthritis Fact Sheet: A Collaborative Initiative with NHIS
- Room 3 (5F)
- KOR (ENG Translation)
- Chairs
- Yoon-Kyoung Sung (Research Director, KCR / Hanyang Univ., Korea)
- Jaiyong Kim (Director, Department of Big Data Management, NHIS, Korea)
17:00-17:10
Overview of the KCR Rheumatoid Arthritis Fact Sheet Initiative
17:10-17:25
How to Conduct Clinical Epidemiology Research with National Health Insurance Data
17:25-17:40
Rheumatoid Arthritis Fact Sheet Results I: Incidence, Prevalence, and Beyond
- May 14 (Thu)
- 14:30-15:30
- Poster Tour 1
- Poster Zone (5F)
- KOR
KP-001
Effect of Febuxostat on Coronary Artery Calcification in Patients with Gout: Pilot Study
KP-002
Association between Serum Uric Acid Levels and Sarcopenia in Korean Adults: A 2022–2023 Korea National Health and Nutrition Examination Survey
KP-003
CRIF1 Deficiency in B Cells Accelerates Sjögren’s Syndrome Pathogenesis by Promoting STAT3-Dependent IL-17 Production and Inflammaging
KP-004
Urinary Proteomic Analysis for the Identification of Differentially Expressed Proteins in Patients with Ankylosing Spondylitis
KP-005
Bone Marrow Activity on 18F-FDG PET/CT: A Predictor of Hematologic Manifestations in Systemic Lupus Erythematosus
- May 14 (Thu)
- 14:30-15:30
- Poster Viewing 1
- Poster Zone (5F)
KP-013
Expression and Clinical Significance of SIRT Family-related Genes and HDAC11 in Peripheral Blood Mononuclear Cells from Patients with Primary Gouty Arthritis
KP-014
Effects of Sodium Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Preventing Acute Gout Flares among Type 2 Diabetic and Non-diabetic Individuals: A Systematic Review and Meta-analysis
KP-015
Progressive Tension Suture Traction Technique for Closure of Post-Gouty Tophus Wound with Exposed Bone and Tendons: A Case Report
KP-016
Dose- and Duration-independent Serum Uric Acid Reduction with Dapagliflozin: A Systematic Review and Meta-analysis of Randomized Controlled Trials
KP-017
Global Divergence in Knee and Hip Osteoarthritis Burden (1990–2023): A Comparative Analysis of Socio-Demographic Disparities and Metabolic Risk Attribution
KP-018
The Study Explores How Nurse Support and Family Stability Jointly Influence Emotional Well-being in SLE Women of Childbearing Age during Contraceptive Use, Testing a Mediation Model of These Relationships
KP-019
Analysis of Risk Factors for Febrile Seizures in Patients with Anti-synthetase Syndrome and Severe Pneumonia: A Cross-sectional Study
KP-020
Phytochemical Analysis of the Traditional Medicine Khamba TD-8 Used for Inflammatory Bone Diseases
KP-021
Impact of Interstitial Lung Disease and Undertreatment on Health-related Quality of Life in Rheumatoid Arthritis
KP-022
Distinct Characteristics of Seronegative IgG4-RD: Preliminary Findings from a Multi-centre Retrospective Study
KP-023
DDR2 Auto-phosphorylation in Patients with Warburg-Cinotti Syndrome Promotes Differentiation of Fibroblasts into Myofibroblasts and Expansion of Immature B Cells with Antibody Production
KP-024
Clinical Alert: Hydroxychloroquine-Induced Pustulosis in an Asian Patient—A Diagnostic Dilemma Successfully Managed with Ixekizumab
KP-025
Weighted Gene Co-expression Network Analysis of PBMC Transcriptomes in Juvenile Dermatomyositis
KP-026
Amyopathic Antisynthetase Syndrome Presenting with Organizing Pneumonia Pattern Interstitial Lung Disease and Anti-PL-7 Antibody Positivity
KP-027
Localized Tenosynovial Giant Cell Tumor of the Knee: Characteristic MRI Findings and Diagnostic Pearls
KP-028
Baseline Blood Pressure and Radiographic Progression of Hand Osteoarthritis: A Longitudinal Study from the Dong-gu Study
KP-029
Role of Weight Loss in Management of Knee Osteoarthritis on Non-diabetic
KP-030
Deep Learning Approach for Automated Radiographic Grading of Knee Osteoarthritis Using Explainable Artificial Intelligence Frameworks
KP-031
TLR4-dependent Up-regulation of IL-22-producing T Cells in the Bone Niche
KP-032
Defining the Immune Landscape of CRMO by Single-cell Transcriptomics: Distinctions from JIA
KP-033
Composite Pediatric Flare Vulnerability Score Integrating Height for Age Deficits Subclinical Inflammatory Load and Infection Related Delays In Biologic Initiation across Resource Limited Asian Rheumatology Settings
KP-034
Thrombocytosis Predicts Response to Biologic and Targeted Synthetic Disease-modifying Anti-rheumatic Drugs in Rheumatoid Arthritis
KP-035
Wogonin Modulates Macrophage Polarization and Inflammatory Signaling through the LSD1-p65 Axis to Alleviate Osteoarthritis
KP-036
Metabolomics Reveals Metabolic Markers for Individuals in Rheumatoid Arthritis Associated Interstitial Lung Disease
KP-037
Trends in Medication Use for Rheumatoid Arthritis: A Single-center 15-year Longitudinal Analysis (2009–2025)
KP-038
Risk of Serious Infections and Malignancy in Elderly Patients with Rheumatoid Arthtitis Treated with JAK Inhibitors Vs Biological DMARDs: A Systematic Review
KP-039
Construction of a Risk Prediction Model for Inflammatory Cytokine Storm in Early Recovery Phase of Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD) Patients
KP-040
Comparison of JAK Inhibitors and Biologics with Respect to Pain Reduction in Patients with Rheumatoid Arthritis: Data from KOBIO Registry
KP-041
Left Ventricular Diastolic Dysfunction among Patients with Rheumatoid Arthritis
KP-042
Distinct Salivary Inflammatory Proteome in Treatment-naïve Rheumatoid Arthritis: A Prospective Study
KP-043
Clinical and Functional Implications of bDMARD Switching in Elderly Rheumatoid Arthritis Patients after 1st bDMARD Failure: Evidence from an Overlap-weighted Real-world Analysis
KP-044
Differentiation of Physiological from Pathological Bone Erosions in Rheumatoid Arthritis: An Eight-year HR-pQCT Study of the Second Metacarpal Head
KP-045
Inflammatory Biomarkers and Bone Loss in Elderly-onset Rheumatoid Arthritis
KP-046
Trends in Permanent Disability Associated with Rheumatoid Arthritis in Korea, 2010–2022
KP-047
Elderly Sjögren Syndrome Multimorbidity Heat Landscape Combining EULAR Disease Activity Score Glandular Dryness Severity Cumulative Glucocorticoid Dose with Incident Diabetes Stroke Lymphoproliferative Malignancy Outcomes
KP-048
Study on the Therapeutic Effect of Magnetic Field Therapy in Ankylosing Spondylitis
KP-049
Incidence of Small Bowel Bleeding in NSAID Using Patients with Radiographic Axial Spondyloarthritis: Data from Korean Health Insurance Service
KP-050
Case of Concurrent Radiographic Axial Spondylitis and Rheumatoid Arthritis
KP-051
Risk of Extra-articular Manifestation in Standard Dose versus Reduced Dose of Tumor Necrosis Factor Inhibitors in Patients with Radiographic Axial Spondyloarthritis: Data from KOBIO Registry
KP-052
Study on the Application of Electromagnetic Wave-Mediated Immune Modulation in Systemic Lupus Erythematosus
KP-053
Disciplinary Variations in the First Renal Biopsy Practice for Lupus Nephritis: Comparative Analysis of Indications and Clinical Presentations between Rheumatology and Nephrology Centers
KP-054
Interrupted Time-series Study on the Impact of Telitacicept for Injection on Adverse Renal Outcomes in Patients with Lupus Nephritis
KP-055
Successful Management of a High-risk Pregnancy in a Patient with Triple-positive Antiphospholipid Syndrome and Systemic Lupus Erythematosus
KP-056
Autoantibody-defined SLE Clusters and Its’ Association with Clinical Characteristics and Medications among Malay SLE Patients: Findings from ILUPUS Study
KP-057
Pseudo-pseudo Meigs Syndrome in a Newly Diagnosed Female Patient with Systemic Lupus Erythematosus: A Case Report
KP-058
Anti-dsDNA Seroconversion and Its’ Association with Medications in Malay Patients with Systemic Lupus Erythematosus
KP-059
Analysis of Factors Associated with Pulmonary Embolism Risk in Patients with Antiphospholipid Syndrome Based on Visual Dynamic Implementation Mapping: A Cross-sectional Study
KP-060
Risk of Alzheimer’s Dementia in Patients with Systemic Sclerosis: Data from Nation-wide Health Insurance Claim Data
KP-061
A Case of IgG4-related Disease with Features of Takayasu's Arteritis
KP-062
Serum Regulator of Cell Cycle Levels Could Serve as a Biomarker for Cross-sectional Assessment of High Disease Activity in ANCA-associated Vasculitis
KP-063
Diagnostic Challenge: Pancreatic Mass in Granulomatosis with Polyangiitis
KP-064
The First Results of 4 Years Prospective Follow-up of an Early Inception Cohort in Takayasu’s Arteritis
KP-065
Non-Pauci-Immune Glomerulonephritis in a Patient with Propylthiouracil-associated ANCA-associated Vasculitis: Case Report
- May 15 (Fri)
- 08:00-09:00
- Breakfast Symposium 1 [Samsung Bioepis]
- Osteoporosis
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Gwan Gyu Song (Korea Univ., Korea)
08:00-09:00
Optimizing Fracture Prevention in Rheumatic Patients: Updates on High-Risk Management Strategies
- May 15 (Fri)
- 09:00-10:00
- Keynote Lecture 1
- Room 1 (3F)
- ENG
- Chair
- Yong-Beom Park (Yonsei Univ., Korea)
09:00-10:00
Central Role for EBV in Systemic Lupus Erythematosus
- May 15 (Fri)
- 10:30-12:00
- International Symposium 1_Mastering the Spondyloarthritis Spectrum
- Room 1 (3F)
- ENG
- Chairs
- Tae-Hwan Kim (Hanyang Univ., Korea)
- Tae-Jong Kim (Chonnam Nat'l Univ., Korea)
10:30-11:00
Past, Present, and New Horizons in Spondyloarthritis Research
11:00-11:30
Long-Term Prognosis and Outcomes from Cohort Data
11:30-12:00
Clinical Trial and Real-World Data for Optimal Treatment Decisions
- May 15 (Fri)
- 12:00-13:00
- Luncheon Symposium 4 [Abbvie]
- Exploring Disease Control Strategies of JAK inhibitor for Rheumatoid Arthritis
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Sang-Cheol Bae (Hanyang Univ., Korea)
12:00-13:00
Optimizing Treatment for Early Remission in Rheumatoid Arthritis with Upadacitinib
- May 15 (Fri)
- 13:00-14:30
- International Symposium 2_KCR-GOUT/G-CAN Joint Symposium
- Room 1 (3F)
- ENG
- Chairs
- Jung Soo Song (Chung-Ang Univ., Korea)
- Seung-Jae Hong (Kyung Hee Univ., Korea)
13:00-13:30
Gout 2026: New Biology, New Therapies
13:30-14:00
Emerging Urate-Lowering Drugs and Their Application to Gout Treatment Strategies
14:00-14:30
Beyond Crystal Deposition: Gouty Tophi as Structured Inflammatory Microenvironments
- May 15 (Fri)
- 15:30-17:00
- International Symposium 3_Contemporary Understanding and Innovative Treatments for Fibromyalgia
- Room 1 (3F)
- ENG
- Chairs
- Hyun Ah Kim (Hallym Univ., Korea)
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
15:30-16:00
Distinguishing Inflammatory and Nociplastic Pain: Clinical Implications for Fibromyalgia and Inflammatory Arthritis
16:00-16:30
EULAR Perspectives on Fibromyalgia: From Pathophysiology to Updated Management Recommendations
16:30-17:00
Is Fibromyalgia an Autoimmune Disease? Rethinking the Evidence
- May 15 (Fri)
- 08:00-09:00
- Breakfast Symposium 2 [Pfizer & Hanlim MS]
- The Role of Xeljanz
- Room 2 (3F)
- KOR (ENG Translation)
- Chair
- Jae-Bum Jun (Hanyang Univ., Korea)
08:00-09:00
As First Approved JAK, Broaden Indications, and Over 10-Year Experience in Korea
- May 15 (Fri)
- 10:30-12:00
- Free Paper Session 5_Osteoarthritis and Pain in Rheumatic Diseases
- Room 2 (3F)
- ENG
- Chairs
- Hyun Sik Gong (Seoul Nat'l Univ., Korea)
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
10:30-10:40
(KO-036) Kindlin-2 Alleviates Osteoarthritis by Regulating Mitochondrial STAT3 Function and Suppressing Inflammatory Cell Death through Mitochondrial Translocation
10:40-10:50
(KO-037) Mito-metformin Ameliorates Osteoarthritis Progression by Restoring Mitochondrial Function and Modulating Chondrocyte Inflammation and Cell Death
10:50-11:00
(KO-038) Intra-articular Delivery of Sox9 mRNA-lipid Nanoparticles Attenuates Osteoarthritis by Enhancing Ciliary Function and Suppressing Wnt Signaling
11:00-11:10
(KO-039) Lubricating MXenzyme Hydrogel Microspheres Orchestrate Innate and Adaptive Immune Modulation for Osteoarthritis Therapy
11:10-11:20
(KO-040) Epigallocatechin Gallate Based pH-Sensitive PEGylated Liposomes Ameliorate Monoiodoacetate-induced Osteoarthritis in Rats via Alteration of HO-1/Nrf2, PI3K/Akt and MAPK Signaling Pathways
11:20-11:30
(KO-041) Topological Analysis of Subchondral Bone Density in Trapeziometacarpal and Scaphotrapezial Arthritis Using Three-dimensional CT
11:30-11:40
(KO-042) Accelerometer-measured Chronoactivity and Osteoarthritis Risk: A Prospective Cohort Study
11:40-11:50
(KO-043) Digital Pain Sentinel for Forecasting Fibromyalgia Pain Surges Using Causal Machine Learning Linking Air Pollution Shocks and Weather Volatility in Asia-Pacific Metropolises
- May 15 (Fri)
- 12:00-13:00
- Luncheon Symposium 5 [Eisai Korea Inc.]
- The Difference among JAK-Inhibitors
- Room 2 (3F)
- ENG
- Chair
- Yong-wook Park (Chonnam Nat'l Univ., Korea)
12:00-13:00
Balancing Efficacy and Safety: Real-World Experience and Clinical Benefits of Filgotinib
- May 15 (Fri)
- 13:00-14:30
- Free Paper Session 6_Rheumatoid Arthritis (I)
- Room 2 (3F)
- ENG
- Chairs
- Jungsik Song (Yonsei Univ., Korea)
- Hae-Rim Kim (Konkuk Univ., Korea)
13:00-13:10
(KO-044) Circular RNA Profile Identifies CircSTRN and CircIRAK3 as Potential Biomarkers of Systemic Juvenile Idiopathic Arthritis
13:10-13:20
(KO-045) Long Non-coding RNA NR_030732 Drives Pathogenic Fibroblast-like Synoviocyte Phenotypes and Osteoclast Differentiation in Rheumatoid Arthritis
13:20-13:30
(KO-046) Therapeutic Efficacy of HzVSF-V13, a Vimentin-targeting Monoclonal Antibody, in Attenuating Rheumatoid Arthritis via Suppression of Th17 Cells and Osteoclastogenesis
13:30-13:40
(KO-047) Changes in Erosion Volume and Functional Outcomes in Early Rheumatoid Arthritis: A Two-year Prospective HR-pQCT Study
13:40-13:50
(KO-048) Clinical-ultrasonographic Discordance in Rheumatoid Arthritis: A Comparative Analysis of Biologic and Targeted Synthetic DMARDs
13:50-14:00
(KO-049) Comparison of Clinical Characteristics and Drug Survivals of Biologic/targeted Synthetic DMARDs between Elderly and Non-elderly D2T-RA Patients: Data from KOBIO Registry
14:00-14:10
(KO-050) DAS28-guided Treatment De-escalation and Risk of Disease Flare in Rheumatoid Arthritis: A Nationwide Registry Study
14:10-14:20
(KO-051) Threshold Dose of Oral Glucocorticoid Therapy on Risk of Serious Infection in Patients with Rheumatoid Arthritis: A Nested Case–control Analysis
14:20-14:30
(KO-052) Effect of Methotrexate Discontinuation on Immunogenicity of Recombinant Zoster Vaccine in Patients with Rheumatoid Arthritis
- May 15 (Fri)
- 15:30-17:00
- Free Paper Session 7_Spondyloarthritis Including Psoriatic Arthritis (I)
- Room 2 (3F)
- ENG
- Chairs
- Seong Ryul Kwon (Inha Univ., Korea)
- Min-Chan Park (Yonsei Univ., Korea)
15:30-15:40
(KO-053) Dynamics of Interleukin-23/Interleukin-17 Axis and Type 1 Regulatory T Cells across Disease Stages in Axial Spondyloarthritis
15:40-15:50
(KO-054) Deep Learning for Assessment of Disease Activity in Patients with Axial Spondyloarthritis Using Combined Sacrum and Spine MRI
15:50-16:00
(KO-055) Development and Validation of the Modified Bath Ankylosing Spondylitis Metrology Index: A Mobile Artificial Intelligence Tool to Measure Spinal Mobility in Axial Spondyloarthropathy
16:00-16:10
(KO-056) ADSC Secretome Exerts Anti-inflammatory Effect in the M5-induced HaCaT Keratinocytes and Murine Model of Psoriasis
16:10-16:20
(KO-057) Novel Serum Biomarkers for Early Prediction of Structure Bone Damage in Psoriatic Arthritis
16:20-16:30
(KO-058) Plasma Glutamate Levels in Treatment-naïve Psoriatic Arthritis Patients and the Correlation with Disease Activity
16:30-16:40
(KO-059) Interpretable Machine Learning Identifies Refractory Inflammatory Immune States in Psoriatic Arthritis and Guides Precision Biologic and JAK Inhibitor Switching
16:40-16:50
(KO-060) Gender-related Differences in Clinical Phenotypes and Musculoskeletal Ultrasound Findings among Chinese Patients with Psoriatic Arthritis
16:50-17:00
(KO-061) Bridging the Gap: A Single Intramuscular Glucocorticoid Injection Provides Rapid and Sustained Benefit in Selected Active Psoriatic Arthritis with a Favorable Safety Profile
- May 15 (Fri)
- 08:00-09:00
- Breakfast Symposium 3 [Celltrion]
- Tocilizumab Biosimilar for Rheumatoid Arthritis
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- Jinseok Kim (Jeju Nat'l Univ., Korea)
08:00-09:00
Demonstrating Efficacy and Safety Equivalence of Avtozma: Results from Phase III Clinical Trial
- May 15 (Fri)
- 10:30-12:00
- KCR-KSBMR Joint Symposium_Clinical Osteoimmunology in Practice
- Room 3 (5F)
- ENG
- Chairs
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- Je-Yong Choi (Kyungpook Nat'l Univ., Korea)
10:30-11:00
Immune Cells and Bone Interaction
11:00-11:30
Cellular Crosstalk in Bone: A Therapeutic Perspective
11:30-12:00
Restoration of BMD by Treatment of Rheumatic Diseases
- May 15 (Fri)
- 12:00-13:00
- Luncheon Symposium 6 [Novartis]
- Bending the AS Curve Early with IL-17A Inhibition
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- Sung Won Lee (Dong-A Univ., Korea)
12:00-13:00
From Early Control to Sustained Outcomes with Secukinumab in AS
- May 15 (Fri)
- 13:00-14:30
- KCR-KCPCI Joint Symposium
- Room 3 (5F)
- ENG
- Chairs
- Youngdae Kim (Inje Univ., Korea)
- Myeungsu Lee (Wonkwang Univ., Korea)
13:00-13:30
Transition Care in Japan
13:30-14:00
Caring for Childhood-Onset SLE in Adult Rheumatology Care
14:00-14:30
Still's Disease across the Age Spectrum: Integrating Recent EULAR/PReS Recommendations
- May 15 (Fri)
- 15:30-17:00
- Health Insurance Committee Session
- Room 3 (5F)
- KOR (ENG Translation)
- Chairs
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- Chong-Hyeon Yoon (The Catholic Univ. of Korea, Korea)
15:30-16:00
Rheumatology Workforce Projections
16:00-16:30
Strategic Responses to Ensure the Supply of Rheumatologists
16:30-17:00
Panel Discussion
Youngsik Bang (Division of Health Personnel Policy, Ministry of Health and Welfare, Korea)
Sukil Kim (The Catholic Univ. of Korea, Korea)
Seung-Jae Hong (Kyung Hee Univ., Korea)
Bo Young Yoon (Inje Univ., Korea)
- May 15 (Fri)
- 14:30-15:30
- Poster Tour 2
- Poster Zone (5F)
- KOR
KP-006
The Aftermath of Urate-lowering TheRApy in Gout (ULTRA) Registry: A Prospective, Multicenter, Observational Cohort of Korean Patients with Gout
KP-007
Switching from Anakinra to Canakinumab in Cryopyrin-associated Periodic Syndrome: Marked Quality-of-life Improvement with Early Dose Optimization
KP-008
Allograft Inflammatory Factor-1 Is Associated with Inflammatory Monocyte Identity and Th17 Polarization in Spondyloarthritis
KP-009
Differential Impact of Social Support and Disease Activity on Depression and Fatigue in Korean Patients with Systemic Lupus Erythematosus
KP-010
Post-operative Outcomes of Cardiovascular Surgery in Patients with Behçet’s Disease: A Nationwide Population-based Study
- May 15 (Fri)
- 14:30-15:30
- Poster Viewing 2
- Poster Zone (5F)
KP-066
Elderly-onset Febrile Polyarthritis as a Diagnostic Pitfall between Polymyalgia Rheumatica and Gout
KP-067
Does Intensive Urate-lowering Therapy Regress High-risk Coronary Plaque? A Prospective Coronary CT Angiography (CCTA) Study in Gout Patients
KP-068
Clinical Utility of Anakinra in Gouty Arthritis: A Systematic Review
KP-069
Diagnostic Accuracy of Dual-energy CT Imaging in Asian Patients with Gout: A Systematic Review and Meta-analysis
KP-070
Effectiveness of Segmented Intelligent Simulation Activity Rooms in Early Rehabilitation Training for Patients with Severe Rheumatic Diseases
KP-071
Association between Childhood Tonsillectomy and Increased Risk of Autoimmune Disease: A Nationwide Population-based Cohort Study
KP-072
Shared Decision-making in Autoimmune Inflammatory Rheumatic Diseases: Patient Perceptions from a Mixed-methods Study
KP-073
ICT-based Health Information Seeking among Patients with Autoimmune Inflammatory Rheumatic Diseases: A Mixed Methods Study
KP-074
Castleman Disease-like Mesenteric Lymphadenopathy in a Korean Adult Ultimately Diagnosed with Familial Mediterranean Fever
KP-075
When Pathology Falls Silent: 68Ga-FAPI PET/CT Unmasks Multiorgan IgG4-Related Disease in a Patient with Inconclusive Histology
KP-076
Machine Learning–based Prediction of One-year Mortality in Adult-onset Still’s Disease Using the Korean National Health Insurance Service Database
KP-077
Characteristics of Anti–MDA5–positive Idiopathic Inflammatory Myopathies: A Cross–sectional Study in Vietnamese Patients
KP-078
Association between Computed Tomography–quantified Abdominal Muscle Mass and Depression in Middle-aged and Older Korean Men
KP-079
The MCP-1-PIEZO1 Axis Drives Osteoarthritis Progression by Linking Mechanotransduction to Mitochondrial-mediated Inflammatory Cell Death
KP-080
Automated Quantitative Morphological Profiling of Hand Arthritis via 3D Scanning: From Volumetric Assessment to Surface Texture Analysis
KP-081
Association between Inflammatory Markers and Impaired Bone Health in Patients with Adult-onset Still’s Disease: A Cross-sectional Study
KP-082
Impact of Fruits and Vegetables Intake on Immune-mediated Inflammatory Diseases: A Two-sample Mendelian Randomization Study
KP-083
Not Behçet: STAT1 Gain-of-function Presenting with Behçet-like Mucosal Ulcers
KP-084
Long-term Efficacy, Safety, and Exploratory Predictors of Response to Combination Therapy with Upadacitinib in Patients with Moderate-to-severe Juvenile Idiopathic Arthritis
KP-085
Concomitant Corticosteroid Use at Initiation of Biologic or Targeted Synthetic Disease-modifying Antirheumatic Drugs Is Associated with Poor Disease Control and Lower Drug Retention in Rheumatoid Arthritis
KP-086
Cause of Death According to Seropositive Rheumatoid Arthritis Status in Patients with Cancer: A Nationwide Multicenter Cohort Study
KP-087
Restoration of CD28 Expression on Immunosenescent Treg by AMPK Activation in Rheumatoid Arthritis
KP-088
Mapping the Global Research Landscape of Artificial Intelligence and Machine Learning Applications in Rheumatoid Arthritis
KP-089
Rheumatoid Arthritis Disease Active Indices: Classification Concordance of CDAI, DAS28-CRP, and DAS28-ESR in the BITORA Cohort
KP-090
Bifidobacterium Longum BFD1R Ameliorates Rheumatoid Arthritis by Modulating the TDCA–PINK1 Axis to Suppress Pathogenic Th17 Differentiation
KP-091
Patient-reported Outcomes and Clinical Remission with SB5 in Rheumatoid Arthritis and Ankylosing Spondylitis: Interim Results from the PRO-SIMILAR Study
KP-092
Real-world Safety and Effectiveness of SB5 (adalimumab Biosimilar) in South Korea: A Real-world Post-marketing Surveillance Data
KP-093
Comparative Effectiveness of Mycophenolate Mofetil + Tacrolimus Versus Pirfenidone Only in Rheumatoid Arthritis and Sjögren’s Syndrome Associated Interstitial Lung Disease
KP-094
Neutrophil Extracellular Traps: A Pathogenic Factor and Potential Inflammatory Marker in Rheumatoid Arthritis
KP-095
Monocyte Extracellular Traps in Rheumatoid Arthritis: Association with Disease Activity
KP-096
Overcoming Optical Attenuation in Fibrosis Imaging: A Pilot Study on ECL Imaging of Lung and Spleen Tissues in RA-ILD Models
KP-097
Feasibility and Validity of Score-based Risk Stratification for Screening of Rheumatoid Arthritis Interstitial Lung Disease
KP-098
Stem Cell-derived Mitochondrial Transplantation Restores Salivary Gland Function by Regulating the Th1/Th17/B17 Axis and Metabolic Homeostasis in Sjögren’s Syndrome
KP-099
Efficacy and Safety of a 12-week Taekwondo-based Exercise Program in Patients with Axial Spondyloarthritis: A Pilot Randomized Controlled Trial
KP-100
Evaluation of the Lumbar Multifidus and Erector Spinae Muscles in Patients with Ankylosing Spondylitis: An Ultrasonographic Study
KP-101
Long-term Incidence of Major Adverse Cardiovascular Events in Psoriatic Arthritis: A 10-year Prospective Follow-up Study Using Coronary CT Angiography
KP-102
Upadacitinib in Anti-TNF–refractory Ankylosing Spondylitis: A Real-world Single-center Experience
KP-103
Mononeuritis Multiplex in Filipino SLE Patients: A Case Series on Peripheral Nerve Involvement
KP-104
Biologic Medicines Adoption in National Formularies Transforms Lupus Outcomes with Declining Organ Damage and Improved Employment Retention Following Policy Implementation across Middle-income Health Systems
KP-105
In-hospital Mortality in Systemic Lupus Erythematosus Patients with and without Acute Myocardial Dysfunction: A Retrospective Comparative Study
KP-106
Immunoglobulin M to Oxidation-specific Epitope in Patients with Systemic Lupus Erythematosus
KP-107
Severe COVID-19 in a Lupus Patient Presenting with Lupus Enterocolitis and Decompensated Liver Failure: A Case Report
KP-108
Dysregulation of Lymphocyte Subsets and Its Contribution to Severe Secondary Infections in SLE
KP-109
Restoring T Cell Homeostasis with Interleukin-2 Therapy in Diffuse Alveolar Hemorrhage Associated with Systemic Lupus Erythematosus
KP-110
Atypical Presentation of Juvenile Systemic Sclerosis: Normotensive Renal Crisis and Chronic Intracranial Hypertension Induced by Corticosteroid Therapy
KP-111
Intravenous Immunoglobulin as an Adjunctive Therapy for Systemic Sclerosis: Real-world Evidence from a Single Center
KP-112
Crescentic Glomerulonephritis in Pediatric Patients at a Single Tertiary Center in Korea: A Case Series of Comparisons of ANCA-associated Vasculitis and Other Etiologies
KP-113
From Nonsystemic Vasculitic Neuropathy to CNS Involvement: A Case Supporting a PNS–CNS Vasculitis Spectrum
KP-114
MPO-ANCA Positive Granulomatosis with Polyangiitis Mimicking IgG4-related Hypertrophic Pachymeningitis: A Diagnostic Pitfall and Severe Infectious Complications
KP-115
Adolescent-onset Eosinophilic Granulomatosis with Polyangiitis Presenting with Peripheral Digital Gangrene and Mononeuritis Multiplex
KP-116
Nailfold Capillaroscopy in Behçet’s Syndrome
KP-117
Endovascular versus Surgical Revascularization in Takayasu Arteritis: An Updated Lesion- and Patient-level Meta-analysis
- May 16 (Sat)
- 08:00-09:00
- Breakfast Symposium 4 [Eisai Korea Inc.]
- Personalized Treatment for RA
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Sang-Heon Lee (Konkuk Univ., Korea)
08:00-09:00
Identifying Right Patients for JAKi Therapy in RA
- May 16 (Sat)
- 09:00-10:00
- Keynote Lecture 2
- Room 1 (3F)
- ENG
- Chair
- Chang Keun Lee (Univ. of Ulsan, Korea)
09:00-10:00
Immune Checkpoint Receptors in Autoimmune Diseases
- May 16 (Sat)
- 10:30-12:00
- International Symposium 4 (KCR-JCR Research Committee)_Translating Genetic Epidemiology into Clinical Rheumatology
- Room 1 (3F)
- ENG
- Chairs
- Hoon-Suk Cha (Sungkyunkwan Univ., Korea)
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
10:30-11:00
Mapping Genetic Architecture of Autoimmune Rheumatic Diseases: From GWAS Discoveries to Mechanistic Insights
11:00-11:30
Genetic Epidemiology in Clinical Rheumatology: Cohort-Based Insights from Korea
11:30-11:50
Panel Discussion_Future Collaboration between KCR and JCR in the Field of Clinical Research
Yoshiya Tanaka (Univ. of Occupational and Environmental Health, Japan)
Sang-Cheol Bae (Hanyang Univ., Korea)
11:50-12:00
KCR–JCR Clinical Research Committee MOU Signing Ceremony
- May 16 (Sat)
- 12:00-13:00
- Luncheon Symposium 7 [Johnson&Johnson]
- SIMPONI IV Efficacy in RA
- Room 1 (3F)
- KOR (ENG Translation)
- Chair
- Jaejoon Lee (Sungkyunkwan Univ., Korea)
12:00-13:00
Rapid Onset Impact of Biologic from the Start: Golimumab IV in RA Treatment
- May 16 (Sat)
- 13:00-15:00
- Medical Humanities Session
- Room 1 (3F)
- KOR (ENG Translation)
- Chairs
- Sang-il Lee (Gyeongsang Nat'l Univ., Korea)
- Sang-Hyon Kim (Keimyung Univ., Korea)
13:00-14:00
Based on Medical Ethics, Physician-Patient Relationship in the Age of Medical Artificial Intelligence
14:00-15:00
Based on Medical Ethics, Physicians' Social Media Use and Social Trust
- May 16 (Sat)
- 08:00-09:00
- Breakfast Symposium 5 [Daewoong]
- The Expanding Therapeutic Spectrum in Rheumatic Diseases
- Room 2 (3F)
- KOR (ENG Translation)
- Chair
- Young Mo Kang (Kyungpook Nat'l Univ., Korea)
08:00-09:00
Clinical and Economic Value of Biosimilars across Therapeutic Areas: Evidence from Adalimumab and Denosumab Biosimilars (Xelenka® and Stoboclo®)
- May 16 (Sat)
- 10:30-12:00
- Free Paper Session 8_Rheumatoid Arthritis (II)
- Room 2 (3F)
- ENG
- Chairs
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- Eon Jeong Nam (Kyungpook Nat'l Univ., Korea)
10:30-10:40
(KO-062) Pediatric JIA Biologic Dosing Fairness Index Integrating Weight Band Thresholds Trough Biologic Levels Syringe Dead Space Wastage and Insurance Tier Inequities across Global Health Systems in Routine Care
10:40-10:50
(KO-063) Construction and Evaluation of a Chronic Arthritis Animal Model Induced by Persistent Activation of Toll-like Receptors via Lipopolysaccharide Stimulation
10:50-11:00
(KO-064) Mathematical Modeling of a Synovial Response Digital Twin Identifies Nonresponse Bifurcation Thresholds to Tumor Necrosis Factor Inhibition in Rheumatoid Arthritis
11:00-11:10
(KO-065) Role of Joint Space Analysis by High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) in Predicting Inflammatory Arthritis among Patients with Arthralgia
11:10-11:20
(KO-066) Tofacitinib and Upadacitinib Attenuate Lung Fibrosis by Modulating JAK/STAT and TGF-β/SMAD3 Signaling Crosstalk: Implications for the Management of Rheumatoid Arthritis-associated Interstitial Lung Disease
11:20-11:30
(KO-067) Impact of Baseline HDL-cholesterol and Early Treatment Patterns on the Risk of Interstitial Lung Disease in Rheumatoid Arthritis: A Nationwide Multicenter CDM-based Cohort Study over 20 Years
11:30-11:40
(KO-068) Cardiovascular Risk Stratification in Rheumatoid Arthritis Integrating Systemic Inflammatory Markers and Treatment Patterns: A Nationwide Multicenter CDM-based Study with over 20 Years of Longitudinal Follow-up
11:40-11:50
(KO-069) Distinct Disease Activity Trajectories with BDMARDs and TsDMARDs in Rheumatoid Arthritis: Insights from the BITORA Prospective Study
11:50-12:00
(KO-070) Winning the Patient’s Perspective: A Head-to-head Meta-analysis of Upadacitinib versus Adalimumab on Pain, Physical Function, and Quality of Life in Rheumatoid Arthritis
- May 16 (Sat)
- 12:00-13:00
- Luncheon Symposium 8 [Amgen & ChongKunDang]
- Optimizing Osteoporosis Care for Rheumatology Patients
- Room 2 (3F)
- KOR (ENG Translation)
- Chair
- Yun Jong Lee (Seoul Nat'l Univ., Korea)
12:00-13:00
Why Prolia? Facts About Biologics and Biosimilars
- May 16 (Sat)
- 13:30-15:00
- Free Paper Session 9_Crystal Arthropathies and Miscellaneous Inflammatory Diseases
- Room 2 (3F)
- ENG
- Chairs
- Chan Hong Jeon (Soonchunhyang Univ., Korea)
- Joong Kyong Ahn (Sungkyunkwan Univ., Korea)
13:30-13:40
(KO-071) Exosomal MiR-1290 from Adult-onset Still’s Disease Patients Drives Macrophage-mediated Inflammation
13:40-13:50
(KO-072) Delineation of Pathogenic IgG4-secreting Cellular Networks in IgG4-related Disease by Spatial Transcriptomic and Proteomic Profiling
13:50-14:00
(KO-073) A Multivariate Genomic Framework Reveals Shared Autoimmune Risk and Immunoregulatory Circuits in Macrophage Activation Syndrome: From Five Independent Clinical Centers
14:00-14:10
(KO-074) Feasibility of Catheterization-free Approach in Idiopathic Retroperitoneal Fibrosis Patients Complicated with Hydronephrosis
14:10-14:20
(KO-075) Comprehensive Extractable Nuclear Antigen Profiling for Predicting Immune Checkpoint Inhibitor–induced Rheumatic Immune-related Adverse Events
14:20-14:30
(KO-076) A Comprehensive Analysis of the Transcriptional Expression Profile and Functional Role of Lactylation-related Genes in Gouty Arthritis
14:30-14:40
(KO-077) The Impact of Temperature Variations on the Risk of Gout Flare: A Time-stratified Case-crossover Study
14:40-14:50
(KO-078) Associations of Physical Activity Pattern with Incident Gout in a Prospective Cohort Study from UK Biobank
14:50-15:00
(KO-079) AI-derived Coronary Plaque Phenotyping to Quantify Anti-inflammatory Treatment Response in Gout
- May 16 (Sat)
- 08:00-09:00
- Breakfast Symposium 6 [Abbvie]
- Exploring Disease Control Strategies of JAK inhibitor for Axial Spondyloarthritis
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- YoungIl Seo (Hallym Univ., Korea)
08:00-09:00
Optimizing Treatment across Diverse Patient Profiles in Axial Spondyloarthritis with Upadacitinib
- May 16 (Sat)
- 10:30-12:00
- Free Paper Session 10_Spondyloarthritis Including Psoriatic Arthritis (II)
- Room 3 (5F)
- ENG
- Chairs
- Sang-Hoon Lee (Kyung Hee Univ., Korea)
- Seonghoon Park (Daegu Catholic Univ., Korea)
10:30-10:40
(KO-080) NSD1, H3K36me1/2 Methyltransferase as a Potential Therapeutic Target in Th17 Cell-mediated Autoinflammatory Disease
10:40-10:50
(KO-081) Associations of RPS10 and DEF6 Polymorphisms with Radiographic Axial Spondyloarthritis in the Korean Population: A Genome-wide Association Study
10:50-11:00
(KO-082) Epigenetic Landscape of Osteoprogenitors in Ankylosing Spondylitis: FOXF2 Methylation as a Key Determinant of Pathological Bone Formation
11:00-11:10
(KO-083) Low TREX1 Levels Dysregulate Cigarette Smoke–mediated Osteoclastogenesis in Ankylosing Spondylitis
11:10-11:20
(KO-084) The Oral-Gut Microbiome Axis in a Korean Cohort with Ankylosing Spondylitis: Initial Analysis from the INTEGRATE Cohort Study
11:20-11:30
(KO-085) Salivary Microbiome Profiles across Disease Activity in Radiographic Axial Spondyloarthritis
11:30-11:40
(KO-086) Impact of Diagnostic Delay on Long-term Radiographic Structural Outcomes in TNF Inhibitor–treated Radiographic Axial Spondyloarthritis
11:40-11:50
(KO-087) Predictors of Treatment Response to IL-17 Inhibitors in Patients with Axial Spondyloarthritis: A Multicenter Real-world Longitudinal Study
11:50-12:00
(KO-088) Comparison of the Risk of Acute Anterior Uveitis Flare between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial
- May 16 (Sat)
- 12:00-13:00
- Luncheon Symposium 9 [JW Pharmaceutical]
- Targeted Therapies in Systemic Vasculitis
- Room 3 (5F)
- KOR (ENG Translation)
- Chair
- Gunwoo Kim (Daegu Fatima Hosp., Korea)
12:00-13:00
The Role of IL-6 Pathway Blockade: Clinical Outcome of Tocilizumab Therapy in GCA
- May 16 (Sat)
- 13:30-15:00
- Free Paper Session 11_Epidemiology & Public Health
- Room 3 (5F)
- ENG
- Chairs
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- Soo-Kyung Cho (Hanyang Univ., Korea)
13:30-13:40
(KO-089) Risk Factors for Cytomegalovirus Reactivation in Patients Receiving Prolonged High-dose Corticosteroids for Rheumatic Diseases: A Retrospective Cohort Study
13:40-13:50
(KO-090) Real-world Incidence of Immune-related Adverse Events and Survival with Immune Checkpoint Inhibitors in Rheumatoid Arthritis Patients: A Nationwide Matched Cohort Study with Cancer Subgroup Analyses
13:50-14:00
(KO-091) Risk Factors Associated with Major Cardiovascular Adverse Event and Heart Failure in Patients with Ankylosing Spondylitis: A Nationwide Nested Case-control Study
14:00-14:10
(KO-092) Real-world Effectiveness of Zoster Vaccine in Rheumatoid Arthritis Patients Initiating Janus Kinase Inhibitors: A Single-center Korean Cohort Study
14:10-14:20
(KO-093) Increased Risk of Cancer in Patients with Mixed Connective Tissue Disease: A Population-based Cohort Study in Korea
14:20-14:30
(KO-094) Early-onset Gout and Risk of Genitourinary Cancers: A Nationwide Cohort Study of 6.5 million Young Adults
14:30-14:40
(KO-095) Risk of Cognitive Disorders in Patients with Primary Sjögren Syndrome: Data from Korean Health Insurance Service
14:40-14:50
(KO-096) Sex Differences in Medication Utilization and Healthcare Costs among Patients with Radiographic Axial Spondyloarthritis: A Nationwide Claims Database Study
14:50-15:00
(KO-097) Infection-related Hospitalization, Treatment Persistence, and Mortality in Patients with Rheumatoid Arthritis Initiating Biologic or Targeted Synthetic DMARDs According to Residential Region and Treating Hospital Location: A Nationwide Cohort Study
- May 16 (Sat)
- 10:00-10:30
- Poster Tour 3
- Poster Zone (5F)
- KOR
KP-011
Free Form IgG Purified from SLE Patients Triggers Inflammatory Cytokine Production via Cytosolic Internalization in Monocytes
KP-012
Clinical Outcomes and Incidence of GCA-spectrum Events in Korean Patients with Polymyalgia Rheumatica: A Retrospective Multicenter Study Based on a Distributed Research Network Analysis
- May 16 (Sat)
- 10:00-10:30
- Poster Viewing 3
- Poster Zone (5F)
KP-118
Health-related Quality of Life of Korean Patients with Gout: From the ULTRA Registry
KP-119
Increased Risk of End-stage Renal Disease among Young Adults with Gout: A Nationwide Population Study
KP-120
Punicalagin Attenuates MSU-induced Gouty Inflammation and Is Associated with the TXNIP–NLRP3 Inflammasome Pathway
KP-121
Extensive Tophaceous Gout Managed with Staged Surgery and Multimodal Therapy: A Case Report
KP-122
Analysis of Factors Associated with Adverse Outcomes in Critically Ill Patients with Rheumatic Diseases During Intensive Care
KP-123
Making Pharmacogenomics Practical in the Clinic: A Seamless Precision Medicine Workflow
KP-124
Rheumatoid Arthritis in Pakistan: A Health Policy Triangle Framework Review for Integrated Public Health Action
KP-125
Treatment Switching Patterns and Long-term Persistence in Patients with Rheumatoid Arthritis Initiating Targeted Therapy: National Multicenter Study
KP-126
Correlation of Tear Inflammatory Mediators and Serum Autoantibodies in Systemic Autoimmune Disorders
KP-127
Sexual Dysfunction and Related Factors in Adult Males with Familial Mediterranean Fever
KP-128
Famial Mediterranean Fever during Pregnancy: A 30 Case Series with 42 Pregnancy
KP-129
Polymyositis Concomitantly with Guillain–Barré Syndrome in a 50-year-old Filipino Female: A Case Report and Review of Related Literature
KP-130
Efficacy of Platelet-rich Plasma for Knee Osteoarthritis: An Umbrella Review of Systematic Reviews And Meta-analyses
KP-131
The Efficacy of Wangbi Capsules in Patients with Knee Osteoarthritis: A Randomized Open-controlled Clinical Trial
KP-132
Macrophage Activation Syndrome in Kawasaki Disease: A Literature Review of Korean Studies
KP-133
Overlap Syndrome in a 6-year-old Girl with JIA And Anti-NXP2 Antibody-positive Dermatomyositis: A Case Report
KP-134
A SHAP-interpretable Machine Learning Model for the Diagnosis of Rheumatoid Arthritis
KP-135
Elderly Rheumatoid Arthritis Fragility Triad Using Gait Speed Home Hazard Index and Biologic Copayment Ceilings to Explain Fall Related Fractures under Public Insurance in Rural Urban Asia
KP-136
Hyaluronic Acid Attenuates Spike Protein-exacerbated Joint Destruction and Pulmonary Fibrosis in a Rheumatoid Arthritis Mouse Model
KP-137
A Journey Management of Interstitial Lung Diseases in Overlap Syndromes of Rheumatoid Arthritis with Systemic Lupus Erythematous (Rhupus Syndromes) on Cambodian Patient
KP-138
Effectiveness and Safety of Methotrexate Double versus Triple Therapy in Rheumatoid Arthritis on Cambodian Patients
KP-139
Rheumatoid Arthritis, Serologic Status and Risk of Heart Failure: A National Cohort Study
KP-140
Carotid and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis Treated with Tocilizumab
KP-141
Chemokine-regulated Migratory Signatures of Citrullinated Antigen–specific Th17 Cells in Rheumatoid Arthritis
KP-142
Efficacy of Vitamin D Supplementation in Rheumatoid Arthritis: An Updated Meta-analysis of Randomized Controlled Trials
KP-143
Long-term Remission and Safety of Janus Kinase Inhibitors versus Biologic DMARDs in Korean Patients with Rheumatoid Arthritis: A National Multicenter Real-world Extension Study
KP-144
Bioinformatics and Artificial Intelligence-integrated Identification and Experimental Validation of RKIP as a Novel Therapeutic Target in Rheumatoid Arthritis
KP-145
Risk of Rheumatoid Arthritis According to Trajectory Patterns of Metabolic Syndrome: Data from Korean National Health Insurance Service Data
KP-146
Late-onset Anti-Ro–Positive Systemic Inflammatory Syndrome Without Sicca: A Case Series Suggesting a Distinct Autoimmune Entity
KP-147
Postpartum Macrophage Activation Syndrome with Fulminant Hepatitis: A Rare and Life-threatening Complication of Primary Sjögren’s Syndrome
KP-148
Efficacy and Safety of Biologic Agents in Ankylosing Spondylitis Patients with End-stage Renal Disease: A Retrospective Cohort Study
KP-149
Gig Worker Psoriatic Arthritis Pain Flares Fatigue Intensity and Abrupt Platform Deactivation Patterns Aligned with Open Mobility Traces and Clinically Verified Flare Epochs
KP-150
Inflammatory and Structural Lesions at Baseline Whole Spine MRI Are Associated with 5-year Spinal Radiographic Progression in Axial Spondyloarthritis
KP-151
Real World Evidence of Guselkumab in Psoriatic Arthritis in Spain
KP-152
Enhancing Detection of Subclinical Cardiac Involvement in Ankylosing Spondylitis: The Role of 3D Systolic Dyssynchrony Index and Autonomic Dysfunction Parameters
KP-153
The Potential of Serum S100A8 as a Diagnostic and Stratification Biomarker for Antiphospholipid Syndrome in APL Carriers
KP-154
Associations between Familial Risk and Clinical and Laboratory Characteristics in Malay Patients with Systemic Lupus Erythematosus
KP-155
Retrospective Analysis of Medication Effects on Disease Activity in Malay SLE Patients
KP-156
Association of Anti-dsDNA Antibodies with Malar Rash, Leukopenia and High Disease Activity in Malay Patients with Systemic Lupus Erythematosus (SLE): Insights from the ILUPUS Study
KP-157
Comparison of the Clinical Characteristics, Laboratory Parameters, Disease Activity Status, and Treatment between Early- versus Late-onset Systemic Lupus Erythematosus among Malay Patients
KP-158
Chilblain Lupus Erythematous-A Rare Encounter
KP-159
Alteration of Ceramide/Sphingosine-1-Phosphate Rheostat in Patients with Systemic Lupus Erythematosus
KP-160
Eosinophilic Fasciitis as a Scleroderma Mimic: A Case Report
KP-161
Integrated Skin Transcriptomic Analysis Identifies Keratinocyte-driven Fibrotic Programs Distinguishing Diffuse and Limited Systemic Sclerosis
KP-162
RNA Sequencing Reveals Distinct Gene Expression Patterns in Overlap and Non-overlap Juvenile Systemic Sclerosis
KP-163
Study on the Early Warning Effect of Remote Monitoring Alert System for Severe Adverse Reactions during Hemodialysis in ANCA-associated Nephritis Patients
KP-164
Large-vessel Vasculitis in a 64-year-old Woman with Treated Ovarian Cancer: A Case Report
KP-165
Clinical Utility of 18F-FDG PET/CT in Patients with Microscopic Polyangiitis and Interstitial Lung Disease: A Retrospective Cohort Study
KP-166
Clinical Effectiveness of Dupilumab in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Observational Study
KP-167
Cutaneous Vasculitis during Treatment with Secukinumab on Psoriatic Arthritis (PsA) on Cambodian Patients
KP-168
Efficacy and Safety of Sarilumab in Polymyalgia Rheumatica: Real-world Multicentre Experience
KP-169
Vasculitic Peripheral Neuropathy in Patients with Provisional Cutaneous Arteritis
